Trial intelligence / Profile preview

Metoprolol for mortality reduction in septic patients

IRCT20180804040695N2Phase 3Completed

Sponsor
Zanjan University of Medical Sciences
Start
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of metoprolol in sepsis, sponsored by Zanjan University of Medical Sciences. Started Mar 2022; status: completed.

02

Drugs

metoprolol
03

Conditions

sepsis

Beyond the preview

Go deeper on IRCT20180804040695N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180804040695N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call